Insider trade

CFO exercised or converted 5,000 GMED derivative securities

Traded Dec 1, 2025 · Filed Dec 4, 2025

Globus MedicalGMED

5,000
Shares · @ $64.44

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Dec 1, 2025
Reporting period: Not applicable
Filed with the SEC: Dec 4, 2025

CFOOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001193125-25-307215
Filed / recorded

Dec 4, 2025, 1:23 AM UTC

Added to OQRO

Oct 6, 2026, 7:37 PM UTC

Parser

form4-xml-v2

Data quality

Needs review

Issuer

GLOBUS MEDICAL INC

Issuer CIK

1237831

Ticker

GMED

Reporting person

Kyle Kline

Relationship

Officer

Officer title

Senior Vice President, CFO

Security

Class A Common Stock

Table

Non-derivative (Table I)

Transaction date

Dec 1, 2025

Transaction code

M

Shares / units

5,000

Price per share

$64.44

Acquired / disposed

Acquired (A)

Shares owned after

13,646

Ownership form

Direct

Amendment

No

Around the same time

Director sold ~$355K of Globus Medical

Scheduled in advance10mo ago

34KShares · @ $25.52

10mo ago

Derivative exercise or conversion — not an open-market buy.

More Official record

34KDerivative units

10mo ago

Derivative exercise or conversion — not an open-market buy.

More Official record